Brought to you by 
BioNano nets $19mm through Nasdaq IPO
23 Aug 2018
Executive Summary
Life sciences instrumentation company BioNano Genomics Inc. (genome mapping systems) netted $19mm in its initial public offering of 3.36mm units at $6.125. Each unit consists of one share of common stock and one warrant to purchase one common share at an exercise price of $6.125. Last month, the company announced it first planned to offer 3.35mm shares between $8-10, but later revised that range to $5-6 for 5.5mm shares, and again updated the offering to a proposed 2.45mm units at a $6-7 price.
Deal Industry
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Nanotechnology, Chips, etc.
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BioNano nets $19mm through Nasdaq IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice